Keyword: drug plan design

94 results found
Is it time to reconsider drug dispensing fee maximums?

In employee benefits plans, maximums and caps on prescription drug dispensing fees are common cost management features. These features are designed to nudge plan members to purchase prescription drugs at pharmacies with lower dispensing fees, lowering their out-of-pocket costs, as well as potentially reducing plan costs for employers. For example, where a drug plan has a $5 dispensing […]

  • February 11, 2020 November 12, 2020
  • 08:30
What tools can employers use to address employees’ sleep concerns?

While insomnia is a disorder, it’s just as commonly a symptom, which most people and physicians don’t grasp, said Dr. Atul Khullar, medical director at the Northern Alberta Sleep Clinic. A lot of times, not sleeping is essentially the body breaking down because of a separate disorder, risk factor or residual symptom of a mental-health […]

Capping drug coverage for rare diseases poses an ethical dilemma

While high-cost specialty medications represent about 30 per cent of drug costs, the total budget impact of rare disease drugs is less than two per cent, said Brad McCaw, associate director of market access at Alexion Pharmaceuticals Canada. Within the high-cost specialty market’s top 20 drugs, only one is designated for rare disease, he said […]

Is innovation causing accessibility, timing issues for private drug plans?

Pharmaceutical companies and private payers can interact in different ways to ensure the right drugs are getting to the right patients, according to Kathy Sotirakos, senior manager of market access and private insurance at Amgen. Real world evidence will help inform better decision-making from a predictability and outcomes perspective, she said during a panel at […]

Collaboration fundamental when managing, altering private drug plans

As the landscape of Canadian drug plan management continues to evolve, several programs are being implemented by insurers and pharmacy benefits managers to help plan sponsors manage costs. Speaking on a panel at Benefits Canada’s 2019 Face to Face Drug Plan Management Forum on Dec. 3 in Toronto, Ned Pojskic, leader of pharmacy and health provider […]

What to expect for health benefits in 2020

Looking ahead to 2020, the big story for health benefits is often avoided because it isn’t easy to address. It’s the elephant in the room. Over the past year, there’s been no shortage of momentum in new and emerging product offerings in the health benefits space — everything from digital cognitive behavioural therapy to virtual […]

  • December 24, 2019 November 12, 2020
  • 06:30
CN Rail workers continue strike over drug benefits, safety concerns

Roughly 3,200 Canadian National Railway Co. workers are on strike with outstanding issues including time-off provisions and lifetime caps on certain benefits. The strike, which began at midnight on Nov. 19, has seen conductors, train personnel and yard workers represented by the Teamsters Canada Rail Conference pushing for further bargaining progress on these issues and others, including safety and fatigue. […]

  • By: Staff
  • November 21, 2019 November 12, 2020
  • 09:23
Brand discount cards increase costs to private insurers by 46%: study

As the popularity of brand discount cards grows among Canadians, how much are people actually saving? And what’s the cost to insurers? In a study published in the Canadian Medical Association Journal, researchers waded through 2.82 million prescriptions for 89 different medications for which patients used brand discount cards. It found patients saved seven per cent, or $3.49 […]

  • By: Staff
  • November 18, 2019 November 11, 2020
  • 10:31
HumanisRx launches medication optimization program

Medication-related issues are negatively affecting employees’ health, causing them to take extended leaves from their jobs and leading to high benefits and disability costs for employers, according to a new white paper by HumanisRx. These issues include incompatible or duplicate drugs, higher than recommended doses, suboptimal therapy and failure to take medications as prescribed. “Our research finds […]

  • By: Staff
  • November 14, 2019 November 12, 2020
  • 15:00
Conference coverage: 2019 Calgary Drug Trends Summit

On Oct. 24, the 2019 Calgary Drug Trends Summit featured presentations to educate plan sponsors and advisors about specific disease states and their challenges, new drug treatment categories and key drug trends facing benefits plans. Here’s what you missed! New drug therapies for common conditions could impact private plan sustainability While medical advancements and drug […]